Press release
In-vitro Transcription Templates Market expected to Witness Huge Revenue Growth to 2031
According to the latest research by InsightAce Analytic, the Global In-vitro Transcription Templates Market Size is valued at USD 277.5 Mn in 2023 and is predicted to reach USD 1,134.1 Mn by the year 2031 at a 19.5% CAGR during the forecast period for 2024-2031.
Request for free Sample Pages:
https://www.insightaceanalytic.com/request-sample/2397
DNA sequences used as templates for in-vitro transcription are essential tools in laboratory research for generating RNA molecules. These templates enable scientists to initiate transcription in a controlled environment, allowing for the production of RNA strands with precise sequences. In-vitro transcription has become a pivotal innovation in molecular biology, unlocking numerous possibilities for scientific and medical advancements.
With growing interest in RNA-based therapies, particularly from the pharmaceutical industry, these templates are gaining attention as crucial components in the development of next-generation treatments. This rising demand presents collaboration opportunities between biotech developers and pharmaceutical firms to innovate and expand therapeutic options.
List of Prominent Players in the In-vitro Transcription Templates Market:
• Thermo Fisher Scientific Inc.
• Promega Corporation
• Agilent Technologies, Inc.
• New England Biolabs
• Takara Bio Inc.
• LGC Limited
• Enzynomics Co. Ltd.
• Enzo Life Sciences, Inc.
• Danaher Corporation
• Genscript Biotech Corporation
• Eurofins Genomics LLC
• TriLink Biotechnologies LLC
• Bioline GMBH
• Lucigen Corporation
• Other Prominent Players
Market Dynamics:
Drivers-
The market for in-vitro transcription templates is experiencing robust growth, largely driven by increased government initiatives and funding aimed at promoting scientific research and innovation. These programs provide essential financial backing for researchers exploring advanced areas such as gene expression, RNA therapeutics, and transcriptomics. The expanding scope of RNA-related applications is significantly contributing to the market's momentum, as more researchers turn to in-vitro transcription templates for precise RNA synthesis and experimental accuracy.
Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2397
Challenges:
Despite promising opportunities, the market faces notable challenges. Strict regulatory frameworks and ethical concerns surrounding applications such as gene editing and RNA-based treatments pose hurdles for developers and researchers. Additionally, the shortage of skilled professionals familiar with complex molecular biology techniques may impede market adoption.
Regional Trends:
The Asia Pacific region is expected to hold a significant share of the in-vitro transcription templates market in the coming years. The projected high growth rate is attributed to increased investments in R&D by both large corporations and emerging biotech firms. The region's adoption of integrated digital and operational technologies also boosts agility in research operations, fostering faster innovation and scalability. As a result, APAC is poised to remain a dynamic contributor to the global market landscape.
Recent Developments:
• In Sept 2023, GenScript Biotech Corporation enhanced its IVT mRNA synthesis offerings by introducing personalized circular RNA (circRNA) and lipid nanoparticles (LNPs) formulation services. GenScript has promptly introduced new contract-manufactured reagent services as a demonstration of their dedication to offering state-of-the-art reagents that facilitate progress in areas such as vaccine development, protein replacement therapies, and gene and cell therapy.
• In September 2022, Thermo Fisher Scientific unveiled tailored Dynabeads technologies that facilitate the large-scale synthesis of mRNA. The DynabeadsTM Streptavidin for In Vitro Transcription & Dynabeads Carboxylic Acid for RNA Purification solutions facilitated the large-scale production and purification of mRNA for vaccine development and manufacturing at a Good Manufacturing Practice (GMP) level.
For More Customization @ https://www.insightaceanalytic.com/customisation/2397
Segmentation of In-vitro Transcription Templates Market-
By Disease Type-
• Cancer
o Solid Tumors
o Colorectal Cancer
o NSCLC
o Melanoma
o Leukemia
o Prostate Cancer
o Others
• Infectious Disease
o Influenza
o COVID-19
o AIDS
o Others
• Lifestyle Disease
• Genetic Disease
• Others
By Treatment
• Vaccine
• Therapeutic
By Research Stage
• Exploratory
• Clinical
By End-User
• Pharmaceutical & Biotechnology Companies
• CROs & CMOs
• Academics & Research
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Get more information:
https://www.insightaceanalytic.com/report/in-vitro-transcription-templates-market/2397
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release In-vitro Transcription Templates Market expected to Witness Huge Revenue Growth to 2031 here
News-ID: 3995012 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Integrated Recirculating Aquaculture System (RAS) Market Current Scenario with F …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Integrated Recirculating Aquaculture System (RAS) Market - (By Grade (Closed Type, Semi-Closed Type), By Application (Outdoor System, Indoor System)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Integrated Recirculating Aquaculture System (RAS) Market Size is valued at USD 5.2 Billion in 2024 and is predicted…
Infant Resuscitators Market Exclusive Report on Current Trends and Future Insigh …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Infant Resuscitators Market - (By Product (Self-inflating Resuscitator, Flow-inflating Resuscitator, T-piece Resuscitator), By Type (Reusable, Disposable), By End-user (Hospitals, Neonatal Care, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Infant Resuscitators Market is valued at US$ 267.8 Mn in 2023, and it is expected…
Incontinence Care Products (ICP) Market is on an Upward Growth Curve
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Incontinence Care Products (ICP) Market- (By Product Type (Absorbents, Non-absorbents), By Usage (Reusable, Disposable), By Gender (Male, Female), By Distribution Channel (E-commerce, Retailer Pharmacies, Hospital Pharmacies), By End-User (Home-based Patients, Hospitals & Ambulatory Surgical Centers (ASCs), Other End Users)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic,…
In Vitro Diagnostic (IVD) Reagents Market Report- Expansive Coverage on the Prof …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global In Vitro Diagnostic (IVD) Reagents Market - (By Type (Antibodies, Purified Proteins and Peptides, Oligonucleotides, Others), By Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Others), By Use (Clinical Use, Research Use, Others), By End User (IVD Manufacturers, Academic Institutes & Research Laboratories, Hospital Laboratories, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…
